By
Dr. Nfifakh Adil
Corresponding Author Dr. Nfifakh Adil
Chu Avicenne Rabat, - Morocco
Submitting Author Dr. Nfifakh Adil
Adenocarcinoma ,Tuberculosis,Kidney
Adil N. Renal Adenocarcinoma On Tuberculosis Nephritis. WebmedCentral UROLOGY 2012;3(6):WMC003515
doi:
10.9754/journal.wmc.2012.003515
This is an open-access article distributed under the terms of the Creative Commons Attribution License(CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
No
Abstract
The association of renal tuberculosis and renal cancer is rare. We report a patient who was followed for lithases kidney. The diagnosis of renal tumor associated was made intraoperatively. A lumpectomy was performed. Histological examination revealed a clear cell renal cell carcinoma redesigned by granuloma-follicular caseo tuberculeux.Le patient was under treatment for bacillary for a period of 9 months (2SRHZ/7RH). The outcome was favorable after a decline of 06 months. The objective of this study is to analyze the pathogenesis, diagnostic aspects and therapeutic modalities of this association, which is exceptional.
Introduction
The association of renal tuberculosis and renal cancer is exceptional; less than fifty cases have been reported in the literature [1]. We report a patient who was followed at the urology department A , through which we will analyze the pathogenesis, diagnostic aspects and therapeutic modalities of this association.
Case Report(s)
This is a patient aged 35 years, having benefited in 2004 from left percutaneous nephrolithotomy for renal stones left who was admitted for three years of back pain again later left after febrile with pus from a left lumbar cutaneous fistula in the context of impaired general condition. clinical examination normal apart from the left lumbar fistula. Radiological assessment: chest radiograph was normal renal ultrasound and CT urography showed the presence of bilateral renal stones: an average of 8 mm caliceal right and 3 lower and middle caliceal millimeter, DMSA has left hydronephrosis (Figure 1) predominant at the middle and lower caliceal group and a left renal fistula perished (Figure 2), on renal scintigraphy showed a left kidney providing 30% of renal function with lesions deep sequelae of lower 2/3 of the left kidney. At surgical exploration, there is a medio renal tumor 1.5 cm lower pole nephrectomy and a tumerectomie were performed. Histological renal tuberculosis is caseo-follicular (Figure 3) associated with renal cell carcinoma type tubulopapillary Fürhman grade 2 (Figure 4). The patient was under treatment for bacillary for a period of 9 months (2SRHZ/7RH). After falling 06 months an ultrasound does not objectified tumor recurrence.
Discussion
Some authors report that kidney cancer occurs in 0.2% of cases of renal tuberculosis. [2] There is a high frequency of this association in the Mediterranean including Spain [2]. The age of onset of this association according to published cases is between 50 and 70 years with a male predominance [3]. For most authors this association could be related to reactivation of latent tuberculosis secondary to local immunosuppression induced by the tumor [4] The clear cell adenocarcinoma is histological form predominantly found associated with renal tuberculosis [2,4]. The association of tuberculous lesions in a tumor from another histologic type has been rarely described two cases of tuberculosis occurring in renal adenocarcinoma tubulopapillary were reported in the literature [5]. Cancer treatment on renal tuberculous nephritis is based on the radical nephrectomy, this one can only be achieved after impregnation with a TB treatment for at least four weeks to prevent secondary infection and spread of Mycobacterium tuberculosis. Currently conservative surgery is increasingly performed for tumors of small size [6].
Conclusion
The originality of our observation is based on the double chance discovery of a tumor of the kidney and renal tuberculosis. Treatment should be adapted to the characteristics of cancer. In case of small tumor polar partial nephrectomy followed or preceded by a TB treatment is possible.
Abbreviations(s)
R : Rifampicine
H: Izoniazide
Z: Pyrazinamide
S: Streptomycine
References
1. NEIBLING H.A., WALTERS W.: Adenocarcinoma and tuberculosis of the same kidney: review of the literature and report of seven cases. J. Urol., 1948, 59, 1022-1026.
2. CONDE REDONDE C., ESTEBANEZ ZARRANZ J., RODRIGUEZ TOVES A., DE CASTRO OLMEDO C., CAMACHO PAREJO J., SANZ SANTACRUZ J., MARTINEZ SEGARRA OCEJA J.M. : Tuberculosis and renal cancer. Actas Urol. Esp., 1999 ; 23 : 617-620.
3. PEYROMAURE M., SEBE P., DARWICHE F., CLAUDE V., RAVERY V.,BOCCON-GIBOD L. : Tuberculose rénale et adénocarcinome du rein: Une association trompeuse. Prog Urol., 2002 ; 12 : 89-91.
4. PATARD J.J., BOUET F., RIOUX-LECLERCQ N., LOBEL B., CATROSQUEMENER V., GUILLE F. : Mécanismes de tolérance immunitaire locale dans les cancers du rein. Prog. Urol., 2002 ; 12 : 205-212.
5. GUILLEMIN P. : Tuberculose et cancer du rein. J. Urol. Nephrol., 1970 ; 10: 964.
6. Adénocarcinome rénal sur néphrite tuberculeuse Amine EL MEJJAD, Hamid FEKAK, Adil DEBBAGH, Abdenbi Saad BENNANI, Mohamed EL MRINI; Progrès en Urologie (2005), 15, 309-311.
Source(s) of Funding
None
Competing Interests
None
Disclaimer
This article has been downloaded from WebmedCentral. With our unique author driven post publication peer
review, contents posted on this web portal do not undergo any prepublication peer or editorial review. It is
completely the responsibility of the authors to ensure not only scientific and ethical standards of the manuscript
but also its grammatical accuracy. Authors must ensure that they obtain all the necessary permissions before
submitting any information that requires obtaining a consent or approval from a third party. Authors should also
ensure not to submit any information which they do not have the copyright of or of which they have transferred
the copyrights to a third party.
Contents on WebmedCentral are purely for biomedical researchers and scientists. They are not meant to cater to
the needs of an individual patient. The web portal or any content(s) therein is neither designed to support, nor
replace, the relationship that exists between a patient/site visitor and his/her physician. Your use of the
WebmedCentral site and its contents is entirely at your own risk. We do not take any responsibility for any harm
that you may suffer or inflict on a third person by following the contents of this website.